麻豆传媒

New York, NY USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 67ffd15e7b629_Screenshot2025-04-16110928.png

Reprogramming Cancer Cells to Treat an Aggressive Type of Leukemia

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
16-Apr-2025 5:15 PM EDT Add to Favorites

麻豆传媒: 67e17b02afb44_Screenshot2025-03-24112003.png

Why Brain Metastases of Breast Cancer Resist a Promising Candidate Therapy

A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of radiotherapy and immunotherapy for the treatment of brain metastases arising from breast cancer鈥攁nd in doing so uncovered approaches to...
24-Mar-2025 6:10 PM EDT Add to Favorites

麻豆传媒: 67d0683f402ad_Screenshot2025-03-11124331.png

Ludwig Harvard鈥檚 Bradley Bernstein elected Fellow of the AACR Academy

Ludwig Cancer Research extends its congratulations to Ludwig Harvard鈥檚 Bradley Bernstein on his election as Fellow of the Academy of the American Association for Cancer Research.
11-Mar-2025 8:00 PM EDT Add to Favorites

麻豆传媒: 67d03c5facfa2_Screenshot2025-03-11093619.png

Ludwig Lausanne鈥檚 Douglas Hanahan Honored for His Contributions to Cancer Research

Ludwig Cancer Research congratulates Douglas Hanahan, Ludwig Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research, on his selection as recipient of the Pezcoller Foundation-AACR International Award for...
11-Mar-2025 9:40 AM EDT Add to Favorites

麻豆传媒: 6716af948d313_Screenshot2024-10-21153953.png

A Remote-Controlled Car for Cancer Immunotherapy

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells鈥攁 type of cancer immunotherapy鈥攖hat can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.
21-Oct-2024 3:45 PM EDT Add to Favorites

麻豆传媒: 6716712ea2ea2_Screenshot2024-05-07111244.png

Ludwig Lausanne Director George Coukos elected to the National Academy of Medicine

Ludwig Cancer Research congratulates Ludwig Lausanne Director George Coukos on his election to the U.S. National Academy of Medicine (NAM). Among the highest honors issued to clinicians and scientists, membership in the Academy recognizes...
21-Oct-2024 11:15 AM EDT Add to Favorites

麻豆传媒: 67094d64a4e27_Screenshot2024-10-11120046.png

An AI-Powered Pipeline for Personalized Cancer Vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence...
11-Oct-2024 12:05 PM EDT Add to Favorites

麻豆传媒: 6707ee0c3fdf6_Screenshot2024-10-10104701.png

The Cause of the Genome's Commonest Mutation Has Been Reassigned

A Ludwig Cancer Research study has punctured a longstanding assumption about the source of the most common type of DNA mutation seen in the genome鈥攐ne that contributes to many genetic diseases, including cancer.
10-Oct-2024 11:05 AM EDT Add to Favorites


See All News

Our Experts on News

Our experts are coming soon...

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Experts

Twitter

Facebook

close
0.28758